A detailed history of Bank Of America Corp transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 339 shares of HCWB stock, worth $322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
339
Previous 156 117.31%
Holding current value
$322
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.42 - $0.7 $76 - $128
183 Added 117.31%
339 $0
Q2 2024

Aug 14, 2024

SELL
$0.64 - $1.68 $160 - $420
-250 Reduced 61.58%
156 $0
Q1 2024

May 15, 2024

BUY
$1.1 - $1.77 $434 - $699
395 Added 3590.91%
406 $0
Q4 2023

Feb 14, 2024

BUY
$0.92 - $2.14 $10 - $23
11 New
11 $0
Q4 2022

Feb 10, 2023

BUY
$1.84 - $2.36 $77 - $99
42 New
42 $0
Q1 2022

May 16, 2022

SELL
$1.9 - $2.73 $22 - $32
-12 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$2.32 - $4.73 $27 - $56
12 New
12 $0

Others Institutions Holding HCWB

About HCW Biologics Inc.


  • Ticker HCWB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,833,100
  • Market Cap $34M
  • Description
  • HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...
More about HCWB
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.